Get started
Author

Nicole Rogers

Observed names: N J Rogers, N Rogers, N.J Rogers
ORCID: 0000-0002-7882-6334
Observed ORCID: 0000-0002-7882-6334
OpenAlex ID: A5102989134
PGE1-Containing Protocols Generate Mature (Leukemia-Derived) Dendritic Cells Directly from Leukemic Whole Blood
2019 · Daniel Christoph Amberger, Fatemeh Doraneh-Gard, et al. · International Journal of Molecular Sciences · 35
PDF
Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro
2021 · Lara Kristina Klauer, Olga Schutti, et al. · Transfusion Medicine and Hemotherapy · 27
PDF
Allorecognition
2001 · I Côté, N.J Rogers, et al. · Transfusion Clinique et Biologique · 10
In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers
2024 · Michael Atzler, Tobias Baudrexler, et al. · International Journal of Molecular Sciences · 9
PDF
Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent.
1990 · B J Aungst, J A Blake, et al. · Journal of Pharmacology and Experimental Therapeutics · 7
P01.10 IFNy secretion of adaptive and innate immune cells as a parameter to display leukaemia derived dendritic cell (DCleu) mediated immune responses in AML
2020 · LK Klauer, O Schutti, et al. · 2
PDF
Donor-specific inhibition of xenoreactive T cells in vitro and in vivo
2000 · Nicole Rogers, Mirenda, et al. · Research Portal (King's College London)
Works count: 7
Citation count: 90
H-index: 5
I10-index: 3
Year
Topic
Type